By Josh White
Date: Friday 09 May 2025
(Sharecast News) - Oxford BioDynamics announced on Friday that its Oxford-based laboratory had been accredited by the UK Accreditation Service (UKAS) as a clinical facility under ISO 15189, enabling it to process 'EpiSwitch' clinical tests in the UK.
The AIM-traded company said it had also completed clinical validation of its EpiSwitch...
or login to read the full story
Email this article to a friend
or share it with one of these popular networks:
You are here: news